597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer
| Autor: | Patrick Forde, Neru Munshi, Ugur Sahin, Oezlem Tuereci, Akin Atmaca, Petra Rietschel, Dániel Deme, Bala Öven, Erdem Göker, Istvan Lang, Patrick Brück, Michael Wenger, Thomas Schell, Kezi Ünsal-Kaçmaz, Janet Markman, Huyuan Yang |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2023-SITC2023.0597 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|